Journal
CANCER LETTERS
Volume 475, Issue -, Pages 22-33Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2020.01.035
Keywords
Artemisinin; NSCLC; ASNS; ER stress
Categories
Funding
- National Key Research and Development Program from the Ministry of Science and Technology of China [2017YFC1700200]
- National Science & Technology Major Project Key New Drug Creation and Manufacturing Program of China [2018ZX09711002]
- National Natural Science Foundation of China [31800693, 21877120, 81430080]
- Personalized Medicines-Molecular Signature-based Drug Discovery and Development of Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12020320]
- Innovation Project of Instrument and Equipment Function Development of the Chinese Academy of Sciences
Ask authors/readers for more resources
Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer-related mortality. Artemisinin (ART) and SOMCL-14.221 (221), a spirobicyclic analogue of ART, have been reported to inhibit the proliferation of A549 cells with unclear underlying mechanism. In the present study, we validated that both ART and 221 inhibited the proliferation and migration of NSCLC cells and the growth of A549 xenograft tumors without appreciable toxicity. The proteomic data revealed proteins upregulated in ART and 221 groups were involved in response to endoplasmic reticulum stress and amino acid metabolism. Asparagine synthetase (ASNS) was identified as a key node protein in these processes. Interestingly, knockdown of ASNS improved the antitumor potency of ART and 221 in vitro and in vivo, and treatments with ART and 221 disordered the amino acid metabolism of A549 cells. Moreover, ART and 221 activated ER stress, and inhibition of ER stress abolished the anti-proliferative effects of ART and 221. In conclusion, this study demonstrates that ART and 221 suppress tumor growth by triggering ER stress, and the inhibition of ASNS enhances the antitumor activity of ART and 221, which provides new strategy for drug combination therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available